NUCLITHERA AS
Signals
- Driftsunderskudd 2025 Siste driftsresultat er negativt (−2,2 mill kr).
NUCLITHERA AS is registered as a limited company in Oslo, Oslo with organisation number 832728462. The business is classified under research and experimental development on natural sciences and engineering (NACE 72.100). The company was incorporated in 2023 and has 7 registered employees. Registered share capital is NOK 1.8m, divided into 1840093 shares. The company's stated purpose is: “Utvikling av medisinske produktkandidater, herunder utvikling og utlisensiering av patenter og andre rettigheter, samt utleie av laboratorieutstyr og konsulenttjenester, og annen virksomhet som har naturlig tilknytning til dette. Selskapet kan eie aksjer og andeler i andre selskaper med lignende virksomhet.”. The most recent filed accounts, for the 2025 financial year, show NOK 4.9m in revenue and NOK −2.2m in operating profit.
Key figures · 2025
Financial health · 2025
Who owns NUCLITHERA AS?
NUCLITHERA AS has 6 registered shareholders:
- SCIENCONS AS 75.5%
- Syntax AS 15.1%
- BLAAHAUGEN AS 3.8%
- ADA HELENA VILMA REPETTO LLAMAZARES 1.9%
- EKORNHUSET AS 1.9%
- SMR HOLDING AS 1.9%
Frequently asked questions about NUCLITHERA AS
Who owns NUCLITHERA AS?
SCIENCONS AS is the largest registered owner, with 75.5%.
What is the revenue of NUCLITHERA AS?
NUCLITHERA AS had revenue of NOK 4.9m in 2025.
Who is the general manager of NUCLITHERA AS?
Ludvik Sandnes is registered as general manager of NUCLITHERA AS.
Where is NUCLITHERA AS based?
NUCLITHERA AS has its business address in Oslo.
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.